• Explore /
  • Poster
  • / Personalized K-Track assay to detect actionable mutations and minimal residual disease in solid tumors.

Personalized K-Track assay to detect actionable mutations and minimal residual disease in solid tumors.

Abstract Poster

Authors

null

Lan N Tu

Medical Genetics Institute, Ho Chi Minh City, Viet Nam

Lan N Tu , Van-Anh Nguyen Hoang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies

Sub Track

Early Detection and Surveillance

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 110)

DOI

10.1200/GO.2023.9.Supplement_1.110

Abstract #

110

Poster Bd #

G5

Abstract Disclosures

Similar Posters

First Author: Michael Mitchell

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.

Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.

First Author: Gong Chen

First Author: Erin Fidyk

First Author: Giulia Maddalena